96 related articles for article (PubMed ID: 16761016)
21. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
[TBL] [Abstract][Full Text] [Related]
22. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.
Winter CC; Long EO
J Immunol; 1997 May; 158(9):4026-8. PubMed ID: 9126959
[TBL] [Abstract][Full Text] [Related]
23. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
24. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
[TBL] [Abstract][Full Text] [Related]
25. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH
J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214
[TBL] [Abstract][Full Text] [Related]
26. TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells.
Dolstra H; Fredrix H; van der Meer A; de Witte T; Figdor C; van de Wiel-van Kemenade E
Bone Marrow Transplant; 2001 May; 27(10):1087-93. PubMed ID: 11438826
[TBL] [Abstract][Full Text] [Related]
27. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
[TBL] [Abstract][Full Text] [Related]
28. NK cell receptors and their ligands in leukemia.
Verheyden S; Demanet C
Leukemia; 2008 Feb; 22(2):249-57. PubMed ID: 18046448
[TBL] [Abstract][Full Text] [Related]
29. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
30. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
32. Immunology. The footprint of a killer.
Kärre K; Schneider G
Nature; 2000 Jun; 405(6786):527-8. PubMed ID: 10850700
[No Abstract] [Full Text] [Related]
33. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.
Fan QR; Long EO; Wiley DC
Nat Immunol; 2001 May; 2(5):452-60. PubMed ID: 11323700
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.
Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T
Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858
[TBL] [Abstract][Full Text] [Related]
35. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors.
Sobecks RM; Ball EJ; Maciejewski JP; Rybicki LA; Brown S; Kalaycio M; Pohlman B; Andresen S; Theil KS; Dean R; Bolwell BJ
Bone Marrow Transplant; 2007 Apr; 39(7):417-24. PubMed ID: 17310134
[TBL] [Abstract][Full Text] [Related]
36. Expression of KIR and C-type lectin receptors in Behcet's disease.
Saruhan-Direskeneli G; Uyar FA; Cefle A; Onder SC; Eksioglu-Demiralp E; Kamali S; Inanç M; Ocal L; Gül A
Rheumatology (Oxford); 2004 Apr; 43(4):423-7. PubMed ID: 14679294
[TBL] [Abstract][Full Text] [Related]
37. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
39. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
